Among adults ages 65 and over, 8% say they have taken a GLP-1 medication for a chronic condition, while just 1% say they have taken these drugs only to lose weight, which may be a reflection of Medicares lack of coverage for prescription drugs used for weight loss
Given the high rate of obesity in the teenage population, it will be valuable to track how recent approvals and label expansions impact this group
Every GLP-1 Medication, Compared Complete 2026 comparison chart A side-by-side comparison of every major FDA-approved GLP-1 medication based on published clinical trial data and FDA labels
Mycetoma of the foot caused by Fusarium solani : identification of the etiologic agent by DNA sequencing
Weight may increase slightly, partly from water retention as GLP-1 mediated effects on fluid balance normalize
However, people with SPCD cannot effectively transport certain long-chain fats into the energy centers of their cells ( mitochondria ) due to severely low carnitine levels [3] [5]